Why did Republican Texas comptroller candidate Don Huffins, through his venture firm HEST Investments, pour $1.8 million into Secretome Therapeutics back in 2024, a biotech outfit pushing regenerative medicine with their lead product, STM-01, derived from neonatal cardiac progenitor cells? sourced from babies under 30 days old, specifically infant heart tissue from newborns with congenital defects undergoing surgery.